MAY 14, 2015 01:30 PM PDT

Germline Cancer Genetics in 2015

Speakers
  • Director, Center for Cancer Genetics and Prevention, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute
    Biography
      Dr. Garber received her MD and MPH in 1981 from Yale University School of Medicine. She served her internal medicine residency at Brigham and Women's Hospital, followed by fellowships in hematology at BWH, medical oncology at DFCI, and biostatistics at the National Cancer Institute. She joined DFCI as a fellow in 1985, and now works as a medical oncologist and clinical cancer geneticist.
      <br />
      <br />

    Abstract:

    Germline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibility genes had been predicted by Knudson and Strong in the so-called "two-hit" hypothesis that was developed based on observations that there were families in which cancers clustered and occurred at younger ages, more often bilaterally in paired organs or as multiple primary tumors, and far more frequently than they did otherwise in the general population. In 2015 there have been hundreds of cancer susceptibility genes identified. Most code for proteins that are involved in DNA repair or other regulatory processes rather than structural proteins. In classical cancer genetics, individuals with cancer or with a family history of the disease may seek evaluation for the possible presence of a cancer predisposition syndrome. If the gene for that syndrome is known, blood or saliva from a family member most likely to carry a predisposing mutation is submitted for analysis to one of the commercial labs. The best candidate in the family would have had a tumor that is a component of the syndrome diagnosed at an early age, for example. Molecular analysis of the germline can be focused on candidate genes (e.g. MMR genes for Lynch syndrome, PTEN for Cowden's syndrome) or performed as part of a panel of cancer susceptibility genes by NGS now available from a number of commercial laboratories. However, incidental identification of germline mutations may now occur in the process of molecular analysis of tumors performed in order to identify therapeutic targets, in the course of which a mutation in a gene that can confer hereditary predisposition may be found. Separate testing of germline material would be indicated to determine whether or not the identified mutation was acquired, and therefore somatic, or germline, which could have implications not only for the patient but also for the family. For some types of cancer, the presence of an underlying hereditary predisposition can affect treatment recommendations or surveillance for additional primary cancers in survivors as well as family members (BRCA1/2 mutations in hereditary breast or ovarian cancer, TP53 mutations in Li Fraumeni Syndrome and radiation oncogenesis, With current whole exome and whole genome analyses being offered to adults and in the prenatal setting, incidental identification of germline mutations in cancer predisposition genes as incidental findings have been part of discussions by genetics and ethicists. Mutations identified in dominant cancer susceptibility genes are on the list of those that should be disclosed in the statement by the American College of Medical Genetics, though there remains some controversy around this issue.


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...